Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Eshetu, Teferi ^a,b   Berens Riha, Nicole ^a   Fekadu, Sintayehu ^b   Tadesse, Zelalem ^b   Gürkov, Robert ^a   Hölscher, Michael ^a   Löscher, Thomas ^a   Miranda, Isabel Barreto ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b JIMMA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE PLUS PROGUANIL; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE; ATOVAQUONE PROGUANIL; ATOVAQUONE-PROGUANIL; CYTOCHROME B; DIHYDROFOLATE REDUCTASE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PROGUANIL;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CODON; CORRELATION ANALYSIS; DNA EXTRACTION; ETHIOPIA; GENE AMPLIFICATION; GENE SEQUENCE; GENE TARGETING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MOLECULAR TYPING; MUTATION; PARASITE IDENTIFICATION; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PROTOZOON MUTATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL; ADOLESCENT; ADULT; CHILD; DNA SEQUENCE; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PARASITOLOGY; POINT MUTATION; RECURRENT DISEASE;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHILD; CHLOROGUANIDE; CYTOCHROMES B; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; ETHIOPIA; FEMALE; FLUORENES; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; QUININE; RECURRENCE; SEQUENCE ANALYSIS, DNA; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 77955182470     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-226     Document Type: Article

References (42)

1. Malaria. World Health Organization, http://www.who.int/mediacentre/ factsheets/fs094/en/print.html
2. Guidelines for malaria treatment. World Health Organization, 2006 http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf
3. Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. TA Abeku GJ van Oortmarssen G Borsboom SJ de Vlas JD Habbema, Acta Trop 2003 87 331 340 10.1016/S0001-706X(03)00123-2 12875926
4. Artemisinins: mechanisms of action and potential for resistance. S Krishna AC Uhlemann RK Haynes, Drug Resist Updat 2004 7 233 44 10.1016/j.drup.2004.07.001 15533761
5. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. SJ Foot JK Thompson AF Cowman DJ Kemp, Cell 1989 57 921 30 10.1016/0092-8674(89)90330-9 2701941
6. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. RN Price AC Uhlemann M van Vugt A Brockman R Hutagalung S Nair D Nash P Singhasivanon TJC Anderson S Krishna NJ White F Nosten, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
7. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. ABS Sidhu SG Valderramos DA Fidock, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034
8. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. C Sisowath PE Ferreira LY Bustamante S Dahlstrom A Martensson A Bjorkman S Krishna JP Gil, Trop Med Int Health 2007 12 736 742 17550470
9. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. MT Duraisingh P Jones I Sambou L von Seidlein M Pinder DC Warhurst, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
10. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281
11. Selection of Plasmodium falciparum pfmdr1 Alleles following Therapy with Artemether-Lumefantrine in an Area of Uganda where Malaria Is Highly Endemic. C Dokomajilar SL Nsobya B Greenhouse PJ Rosenthal G Dorsey, Antimicrob Agents Chemother 2006 50 1893 1895 10.1128/AAC.50.5.1893-1895.2006 16641472
12. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. A Martensson J Stromberg C Sisowath MI Msellem JP Gil SM Montgomery P Olliaro AS Ali A Bjorkman, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624
13. Artemisinins target the SERCA of Plasmodium falciparum. U Eckstein-Ludwig RJ Webb DA van Goethem JM East AG Lee M Mimura PG Bray SA Ward S Krishna, Nature 2003 424 957 961 10.1038/nature01813 12931192
14. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. AC Uhlemann A Cameron U Eckstein-Ludwig J Fischbarg P Iserovich FA Zuniga M East A Lee L Brady RK Haynes S Krishna, Nat Struct Mol Biol 2005 12 628 629 Epub 10.1038/nsmb947 15937493
15. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. R Jambou E Legrand M Niang N Khim P Lim B Volney MT Ekala C Bouchier P Esterre T Fandeur O Mercereau-Puijalon, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
16. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2-ATPase), tctp, mdr1, and cg10. A Afonso P Hunt S Cheesman AC Alves CV Cunha V do Rosario P Cravo, Antimicrob Agents Chemother 2006 50 480 489 10.1128/AAC.50.2.480-489.2006 16436700
17. Resistance to dihydroartemisinin. S Cojean V Hubert J Le Bras R Durand, Emerg Infect Dis 2006 12 1798 1799 17283645
18. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. C Wongsrichanalai SR Meshnick, Emerg Infect Dis 2008 14 716 719 10.3201/eid1405.071601 18439351
19. Artemisinin resistance in Cambodia 1 (ARC1) study consortium. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
20. Ariey: Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. P Lim AP Alker N Khim NK Shah S Incardona S Doung P Yi DM Bouth C Bouchier OM Puijalon SR Meshnick C Wongsrichanalai T Fandeur J Le Bras P Ringwald, Malar J 2009 8 11 10.1186/1475-2875-8-11 19138391
21. Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. R Gürkov T Eshetu IB Miranda N Berens-Riha Y Mamo T Girma E Krause M Schmidt JM Hempel T Löscher, Malar J 2008 7 179 10.1186/1475-2875-7-179 18796142
22. Malaria diagnosis and treatment guidelines for health workers in Ethiopia. Federal Democratic Republic of Ethiopia MoHAAE, 2 2004
23. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. KC Kain DE Lanar, J Clin Microbiol 1991 29 1171 1174 1864936
24. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. G Snounou S Viriyakosol XP Zhu W Jarra L Pinheiro VE do Rosario S Thaithong KN Brown, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
25. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. G Snounou HP Beck, Parasitol Today 1998 14 462 467 10.1016/S0169-4758(98)01340-4 17040849
26. Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. T Jelinek AM Ronn MM Lemnge J Curtis J Mhina MT Duraisingh IC Bygbjerg DC Warhurst, Trop Med Int Health 1998 3 605 609 10.1046/j.1365-3156.1998.00280.x 9735930
27. Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. TPF Flueck T Jelinek AHD Kilian IS Adagu G Kabagambe F Sonnenburg DC Warhurst, Trop Med Int Health 2000 5 174 178 10.1046/j.1365-3156.2000.00543.x 10747279
28. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. B Schwöbel M Alifrangis A Salanti T Jelinek, Malar J 2003 2 5 10.1186/1475-2875-2-5 12665429
29. Detection of novel point mutations in the Plasmodium falciparum candidate gene for resistance to artemisinins. M Menegon AR Sannella G Majori C Severini, Parasitol Int 2008 57 233 235 10.1016/j.parint.2007.12.004 18187359
30. New Pf mutations found in Plasmodium falciparum isolates from Vietnam. L Bertaux LH Quang V Sinou NX Thanh D Parzy, Antimicrob Agents Chemother 2009 53 4570 4571 10.1128/AAC.00684-09 19687249
31. (R)) against Plasmodium falciparum in Kersa, South West Ethiopia. A Assefa M Kassa G Tadese H Mohamed A Animut T Mengesha, Parasite Vectors 2010 3 1 10.1186/1756-3305-3-1
32. Efficacy of six-dose regimen of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria, three years after its introduction into Ethiopia. T Kefyalew A Animut T Tamene D Jima A Hailemariam M Legesse, Parasite 2009 16 129 134 19585891
33. Basic Local Alignment Search Tool. http://blast.ncbi.nlm.nih.gov/Blast. cgi
34. Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. R Jambou A Martinelli J Pinto S Gribaldo E Legrand M Niang N Kim L Pharath B Volnay MT Ekala C Bouchier T Fandeur P Berzosa A Benito ID Ferreira C Ferreira PP Vieira MG Alecrim O Mercereau-Puijalon P Cravo, PLoS One 2010 5 9424 10.1371/journal.pone.0009424 20195531
35. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. M Schunk WP Kumma IB Miranda ME Osman S Roewer A Alano T Löscher U Bienzle FP Mockenhaupt, Malar J 2006 5 54 10.1186/1475-2875-5-54 16817953
36. Drug resistance in malaria. U Farooq RC Mahajan, J Vector Borne Dis 2004 41 3-4 45 53 15672556
37. A strong association between mefloquine and halofantrine resistance and amplification, over expression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. SA Peel P Bright B Yount J Handy RS Baric, Am J Trop Med Hyg 1994 51 648 658 7985758
38. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia. T Gebru-Woldearegai A Hailu MP Grobusch JF Kun, Am J Trop Med Hyg 2005 73 1131 1134 16354825
39. A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children. M Mulenga F Malunga S Bennett PE Thuma C Shulman K Fielding A Alloueche BM Greenwood, Trop Med Int Health 2006 11 1643 1652 10.1111/j.1365-3156.2006.01726.x 17054743
40. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune North American traveller to west Africa. S Kuhn MJ Gill KC Kain, Am J Trop Med Hyg 2005 72 407 409 15827276
41. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. JJ Kessl KH Ha AK Merritt BB Lange P Hill B Meunier SR Meshnick BL Trumpower, J Biol Chem 2005 280 17142 17148 10.1074/jbc.M500388200 15718226
42. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia. T Gebru A Hailu PG Kremsner JF Kun MP Grobusch, Malar J 2006 5 112 10.1186/1475-2875-5-112 17118179